Nanoleq acquired by Myant to advance preventive healthcare through smart textiles
18.11.2024
Nanoleq, a leader in bio-signal monitoring and smart textiles, has joined Myant to drive innovation in preventive healthcare. The company will focus on early detection of cardiac and pulmonary conditions.
Nanoleq, a Swiss startup specializing in bio-signal monitoring solutions and smart textiles, has been acquired by Myant, a global leader in textile-based healthcare technology. This acquisition combines Nanoleq's expertise in innovative, sensor-embedded textiles with Myant’s focus on preventive healthcare solutions.
The collaboration aims to transform healthcare by shifting from reactive treatment to early detection and proactive care, addressing conditions like cardiac and pulmonary diseases. Nanoleq's journey, marked by forward-looking technologies and sustained market growth, reflects the dedication of its team and partners.
The deal signals the growing importance of integrating technology into everyday life to promote better health outcomes and prevention-focused healthcare systems.
Nanoleq participated in Venture Leaders Technology in 2020, was ranked among the TOP 100 Swiss Startups from 2018 to 2022, and won Venture Kick in 2017.
Nanoleq team
The collaboration aims to transform healthcare by shifting from reactive treatment to early detection and proactive care, addressing conditions like cardiac and pulmonary diseases. Nanoleq's journey, marked by forward-looking technologies and sustained market growth, reflects the dedication of its team and partners.
The deal signals the growing importance of integrating technology into everyday life to promote better health outcomes and prevention-focused healthcare systems.
Nanoleq participated in Venture Leaders Technology in 2020, was ranked among the TOP 100 Swiss Startups from 2018 to 2022, and won Venture Kick in 2017.
Nanoleq team